Summit Partners Public Asset Management’s RxSight RXST Stock Holding History

Summit Partners Public Asset Management’s Portfolio RXST Stock Details RXST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-687,711	Closed	-$34M	–	182
2024 Q3	$34M	Sell	687,711 -126,122	-15%	-$6.46M	1.05%	33
2024 Q2	$49M	Buy	813,833 +30,764	+4%	+$1.76M	1.87%	19
2024 Q1	$40.4M	Buy	783,069 +496,648	+173%	+$24.4M	1.39%	26
2023 Q4	$11.5M	Buy	+286,421	New	+$8.4M	0.48%	79

Other funds holding RXST

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Summit Partners Public Asset Management's RXST Position: Q4 2024 in Review

Summit Partners Public Asset Management sold out of RxSight (RXST) in Q4 2024, closing a stake of 687,711 shares — an estimated $34M sold.

Summit Partners Public Asset Management first reported a position in RXST in Q4 2023 and held it in 4 quarters. The position peaked at $49M in Q2 2024. 212 funds tracked by Wall St. Rank hold RXST as of Q4 2024.

Summit Partners Public Asset Management reported no remaining RxSight position as of Q4 2024 after selling out during the quarter.
Summit Partners Public Asset Management sold 687,711 RxSight shares in Q4 2024, an estimated $34M.
Summit Partners Public Asset Management first reported a position in RxSight in Q4 2023 and held it in 4 quarters.
Summit Partners Public Asset Management's RxSight position peaked at $49M in Q2 2024.
212 funds tracked by Wall St. Rank held RxSight as of Q4 2024.

Based on Summit Partners Public Asset Management's 13F filing for Q4 2024, filed 14 Feb 2025.